CIEN · NYSE
| FY2026 | FY2025 | FY2023 | FY2022 | FY2021 | FY2020 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $4.77B | $4.01B | $4.39B | $3.63B | $3.62B | $3.53B | $3.57B | $3.57B |
| Cost of Revenue | $2.76B | $2.30B | $2.51B | $2.07B | $1.90B | $1.88B | $2.03B | $2.03B |
| Gross Profit | $2.00B | $1.72B | $1.88B | $1.56B | $1.72B | $1.65B | $1.54B | $1.54B |
| Research & Development | $848.33M | $767.50M | $750.56M | $624.66M | $536.67M | $529.89M | $548.14M | $548.14M |
| Selling, General & Administrative | $238.71M | $220.65M | $215.28M | $179.38M | $181.87M | $169.55M | $174.40M | $174.40M |
| Operating Expenses | $1.81B | $1.55B | $1.52B | $1.34B | $1.23B | $1.17B | $1.20B | $1.20B |
| Operating Income | $197.53M | $166.62M | $357.55M | $222.81M | $495.36M | $486.96M | $346.77M | $346.77M |
| Interest Expense | — | — | $88.03M | $47.05M | $30.84M | $31.32M | $37.45M | $37.45M |
| Other Income / (Expense) | -$2.36M | -$1.58M | -$5.05M | -$5.92M | -$533.00K | -$1.11M | -$737.00K | -$737.00K |
| Income Before Taxes | $156.29M | $119.85M | $323.65M | $182.50M | $462.75M | $455.96M | $313.19M | $313.19M |
| Provision for Income Taxes | $32.95M | $35.89M | $68.83M | $29.60M | -$37.45M | $94.67M | $59.76M | $59.76M |
| Net Income | $123.34M | $83.96M | $254.83M | $152.90M | $500.20M | $361.29M | $253.43M | $253.43M |
| Basic EPS | $0.87 | $0.58 | $1.71 | $1.01 | $3.22 | $2.34 | $1.63 | $1.63 |
| Diluted EPS | $0.85 | $0.58 | $1.71 | $1.00 | $3.19 | $2.32 | $1.61 | $1.61 |
| Basic Shares Outstanding | 142.22M | 144.72M | 148.97M | 151.21M | 155.28M | 154.29M | 155.72M | 155.72M |
| Diluted Shares Outstanding | 145.25M | 145.96M | 149.38M | 152.19M | 156.74M | 155.96M | 157.61M | 157.61M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Oct 2026 | $5.40 | $5.30 | $5.56 | 9 | ↑0 ↓0 |
| Oct 2027 | $8.48 | $6.44 | $10.18 | 9 | ↑0 ↓0 |
| Oct 2028 | $11.89 | $11.73 | $12.05 | 2 | ↑0 ↓0 |